Features
Anti-VEGF Therapy for Retinopathy of Prematurity
Intravitreal agents that inhibit vascular endothelial growth factor are increasingly used to treat pediatric retinal disease.
By Vernon S. Volante, BS, Lauren C. Kiryakoza, MD, Hong-Uyen Hua, MD
The Evolution of Clinical Trial Endpoints for Wet AMD
As new treatments are introduced, the endpoints that drive regulatory approvals are constantly changing.
By Ruwan Amila Silva, MD, MPhil
Web Exclusives
Results of Recent Trials of Duravyu for Wet AMD
Phase 2 trials showed promise and phase 3 trials will begin shortly.
By Carl D. Regillo, MD, FACS
A Plan for Biosimilar Integration
Incorporating biosimilars into a retina practice requires thoughtful planning, diligent oversight, and an adaptable mindset.
By Derek Burns, PharmD, MBA, BCPS, BCSCP, Lisa Lasita, PharmD, MBA
Supported Content
Optos Ultra-Widefield Image of the Month
UWF-RGB Reveals Bone Spicules, Pallorous Halo & Sclerotic Vessels
By Liliya Sutherland, DO
Departments
Upfront: Time for Fewer, But Stronger, Retina Societies
By Peter K. Kaiser, MD
Uveitis Corner: Conserved Chemokine Gradients in Uveitis
A recent study suggests that therapeutically targeting ocular macrophages and the chemokines CCL2 and/or CXCL10 may provide an effective strategy for treating uveitis.
By Lynn Hassman, MD, PhD, Joseph Lin, BS, Kathryn L. Pepple, MD, PhD
Clinical Trial Download: The Potential of Optogenetic Therapy
Nanoscope Therapeutics’s MCO-010 offers an interesting mechanism of action for restoring vision in patients with retinitis pigmentosa and Stargardt disease.
By Yasha Modi, MD , Allen C. Ho, MD, Sulagna Bhattacharya, MBA
Participating in Clinical Trials as a Retina Specialist
A Conversation with David A. Eichenbaum, MD, FASRS
By David A. Eichenbaum, MD
Coding: Separate Procedures and NCCI Bundles
In certain cases, procedures that are usually bundled under NCCI edits can be reimbursed when performed as a distinct service.
By Brandy H. Sperry, COMT, COE, CPC, CPMA
Clinical Trial Update October 2024
Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.